Venous thromboembolism in COPD hospitalized patients

被引:0
作者
Raquel Barba
Antonio Zapatero
Javier Marco
Juan E. Losa
Susana Plaza
Jose Manuel Casas
Jesús Canora
机构
[1] Hospital Infanta Cristina,Servicio de Medicina Interna
[2] Hospital Universitario de Fuenlabrada,Servicio de Medicina Interna
[3] Hospital Clínico de San Carlos,Servicio de Medicina Interna
[4] Hospital Universitario Fundación Alcorcón,Servicio de Medicina Interna
[5] Hospital Severo Ochoa,Servicio de Medicina Interna
来源
Journal of Thrombosis and Thrombolysis | 2012年 / 33卷
关键词
Venous thrombosis; COPD; Hospitalized patients;
D O I
暂无
中图分类号
学科分类号
摘要
Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for venous thromboembolism (VTE). We analyzed a large Spanish database to determine the incidence of VTE in these patients during hospitalization. A retrospective chart review of cohort of consecutive patients admitted with COPD as the primary reason for discharge in Spain between January 1st 2006 and December 31st 2007 was performed. For each patient, demographic data, risk factors for VTE and the diagnosis of VTE during hospitalization was recorded. We analyzed the clinical data of 313,233 adults with acute exacerbations of COPD admitted to the hospital at any public centre in Spain, in 2006 and 2007. We identify 3,562 new diagnosed VTE events among 270,840 COPD patients hospitalized more than two days (incidence 1.32%). Hospitalized-acquired VTE risk factors were male gender (odds ratio [OR] 1.77; CI95% 1.66–1.90), neoplasic disease (OR 2.93 CI95% 2.69–3.16, systemic arterial disease (OR 1.17 CI95% 1.10–1.36), decubitus ulcer (OR 1.19 CI95% 1.01–1.43), diabetes (OR 0.74 IC95% 0.69–0.81), and atrial fibrillation (OR 0.79 CI95% 0.72–0.87). VTE appears as a major threat to patients admitted for acute exacerbation of COPD, and pharmacologic prophylaxis should be considered in all high risk situations.
引用
收藏
页码:82 / 87
页数:5
相关论文
共 93 条
  • [1] Agnelli G(2000)Prevention of venous thromboembolism Thromb Res 97 V49-V62
  • [2] Sonaglia F(2008)Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th ed) Chest 133 381S-453S
  • [3] Geerts W(2004)Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study Arch Intern Med 164 963-968
  • [4] Bergqvist D(2007)Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients N Engl J Med 356 1438-1444
  • [5] Graham FP(2004)Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 874-879
  • [6] Alikhan R(1999)A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group N Engl J Med 341 793-800
  • [7] Cohen AT(2007)Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost 5 1610-1616
  • [8] Combe S(2001)Benefits of deep-vein thrombosis prophylaxis in the nonsurgical patient: the MEDENOX trial Semin Hematol 38 31-38
  • [9] Francis CW(2007)Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism Chest 132 936-945
  • [10] Leizorovicz A(2010)Venous thromboembolism in acutely ill hospitalized medical patients Thromb Res 126 276-279